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Effi cacy of transdiagnostic cognitive-behavioral therapy for anxiety 
and depression in adults, children and adolescents: A meta-analysis
Julia García-Escalera, Paloma Chorot, Rosa M. Valiente, José M. Reales, & Bonifacio Sandín 
Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain
Abstract: This meta-analysis examined the effect of transdiagnostic cognitive-behavioral therapy (T-CBT) in adults, children, 
and adolescents with emotional disorders, exploring the effects of possible moderator variables on effi cacy. In contrast with 
previous reviews, only studies employing transdiagnostic theory-based protocols were included. A total of 48 studies reporting 
on 6291 participants were identifi ed. Treatment effi cacy was examined using a random effects model and taking into account 
pre- and post-treatment data. Results within the adult population showed large overall effect sizes on anxiety (randomized con-
trolled trials [RCTs]: g = 0.80; Uncontrolled studies: g = 1.02) and depression (RCTs: g = 0.72; Uncontrolled studies: g = 1.08) 
that were stable at follow up. Preliminary analysis with children and adolescents showed medium effect sizes on anxiety 
(g = 0.45) and depression (g = 0.50). No signifi cant differences between T-CBT and disorder-specifi c CBT were found. Overall, 
results support the effi cacy of T-CBT for emotional disorders.
Keywords: Transdiagnostic; cognitive-behavioral therapy; anxiety; depression; internalizing disorders; meta-analysis.
Efi cacia de la terapia cognitivo conductual transdiagnóstica en el tratamiento de la ansiedad y la depresión en adultos, niños 
y adolescentes: Un meta-análisis 
Resumen: El presente meta-análisis examina el efecto de la terapia cognitivo conductual transdiagnóstica (TCC-T) en adultos, 
niños y adolescentes con trastornos emocionales, explorando los efectos de posibles variables moderadoras en su efi cacia. A 
diferencia de los meta-análisis previos, sólo se incluyeron los estudios que emplearon protocolos basados explícitamente en el 
enfoque transdiagnóstico. Se identifi caron 48 estudios que informaron sobre 6291 participantes. La efi cacia del tratamiento se 
examinó utilizando un modelo de efectos aleatorios y teniendo en cuenta los datos pre y post-tratamiento. Los resultados sobre 
población adulta muestran tamaños del efecto elevados para la ansiedad (ensayos controlados aleatorizados [ECAs]: g = 0.80; 
Estudios no controlados: g = 1.02) y la depresión (ECAs: g = 0.72; Estudios no controlados: g = 1.08), que permanecieron esta-
bles durante el seguimiento. El análisis preliminar con población de niños y adolescentes mostró tamaños del efecto medios en 
ansiedad (g = 0.45) y depresión (g = 0.50). No encontramos diferencias signifi cativas entre la TCC-T y la TCC para trastornos 
específi cos. En general, los resultados apoyan la efi cacia de la TCC-T para los trastornos emocionales.
Palabras clave: Transdiagnóstico; terapia cognitivo conductual; ansiedad; depresión; trastornos internalizados; meta-análisis. 
Introduction
The development of disorder-specifi c cognitive-behav-
ioral therapies (CBT) for anxiety and depressive  disorders 
is a landmark for the progress of clinical psychology. This 
approach is based on specifi ed cognitive-behavioral mod-
els which explain the processes that hypothetically main-
tain each specifi c anxiety or depressive disorder, including 
principles such as habituation, cognitive avoidance, extinc-
tion, cognitive schemas, self-effi cacy, emotional process-
ing, and inhibitory learning. This theory-driven approach 
has led to the creation of manualized diagnosis-specifi c 
treatments which apply several evidence-based treatment 
components targeted to specifi c disorders, including psy-
choeducation, cognitive restructuring, coping skills, and 
situational and interoceptive exposure. 
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For anxiety disorders, and to a lesser degree for 
unipolar depression, one result of this orientation has 
been the proliferation of treatment manuals for differ-
ent anxiety disorders, especially for panic disorder, so-
cial phobia, generalized anxiety disorder, and posttrau-
matic stress disorder (Craske, 2012; McManus, 
Shafran, & Cooper, 2010; Sandín, Chorot, & Valiente, 
2016). A number of these treatments have been rigor-
ously evaluated in randomized controlled trials and 
designated as empirically validated protocols (i.e., evi-
dence-based CBT) or well-established treatments and 
have been included in current recommended guidelines 
(McManus et al., 2010; Nathan & Gorman, 2015). 
Given the high prevalence and impact of anxiety and 
depressive disorders, disorder-specific treatments have 
brought with them enormous progress and benefits. 
However, this approach is not without significant 
problems. 
A main diffi culty related to this diagnosis-specifi c 
perspective is that people often meet criteria for more 
than one disorder. In fact, for anxiety and depressive dis-
orders, comorbidity is more the norm than the exception. 
For example, Brown and Barlow (2002) reported that 
55% of patients with a principal emotional disorder 
(anxiety or depressive disorder) had at least one addi-
tional current emotional disorder, and the rate increased 
to 76% when lifetime diagnoses were considered. Ac-
cording to these authors, the highest comorbidity rates 
were associated with a principal diagnosis of posttrau-
matic stress disorder (PTSD), major depressive disorder 
(MDD), dysthymia (DYS) and generalized anxiety dis-
order (GAD). Likewise, it has been estimated that about 
40-80% of patients with an anxiety disorder meet diag-
nostic criteria for at least one other anxiety disorder at 
the same time (McManus et al., 2010; Mineka, Watson, 
& Clark, 1998).
Existing literature indicates similar results for chil-
dren and adolescents, estimating the rate of comorbidity 
with anxiety disorders from 30% to 75% (Mineka et al., 
1998). In treatment-seeking samples of children/adoles-
cents, the rates of comorbidity for anxiety and depres-
sion can be as high as 70% (Birmaher et al., 1996). In 
addition to these high rates of Axis I comorbidity be-
tween anxiety and depression, anxiety and depressive 
disorders “not otherwise specifi ed” (NOS) also co-occur 
at rates ranging from 8% to two-thirds according to epi-
demiological studies. It is important to note that emo-
tional disorders share common symptoms (e.g., panic 
attacks, embarrassment, persistent thoughts, emotional 
avoidance, repeated checking), creating challenges in 
differentiating one disorder from another (McManus et 
al., 2010; Mineka et al., 1998). 
Comorbidity has been suggested as a clear threat to 
the effi cacy and effectiveness of diagnosis-specifi c CBT. 
The high comorbidity in emotional disorders is a prob-
lem for clinicians because most patients present with 
more than one disorder, and the evidence-based CBT 
protocols are specifi c manuals designed for specifi c dis-
orders. Evidence-based interventions for anxiety and de-
pression have traditionally been disorder-specifi c, often 
excluding individuals experiencing this common comor-
bidity (Ehrenreich-May, Bilek, Queen, & Hernandez 
Rodriguez, 2012). Though diagnosis-specifi c treatments 
for a given anxiety disorder may produce post-treatment 
reductions in additional comorbid anxiety or depressive 
disorders that were not specifi cally addressed, these out-
comes are not durable and consistent (Brown, Antony, & 
Barlow, 1995; Norton & Philipp, 2008). Similarly, the 
effi cacy of CBT protocols for specifi c anxiety or depres-
sion in children/adolescents is weaker when comorbid 
depression or anxiety, respectively, is present (Ehrenre-
ich-May et al., 2012). 
Several other limitations of disorder-specifi c treat-
ments include (1) the proliferation of manualized treat-
ments for different disorders (sometimes with multiple 
versions for the same disorder and with only trivial 
changes), (2) the fact that a considerable number of pa-
tients do not respond well to this form of treatment, and 
(3) the dissemination of a larger number of different pro-
tocols to providers, which is a major barrier to delivery 
of evidence-based practice in service settings (Craske, 
2012). 
The conceptual overlap among anxiety disorders, the 
common clinical features across anxiety and depressive 
disorders (overestimation of threat, shared symptoms, 
etc.), the communalities in cognitive, behavioral and 
emotional areas of dysregulation (emotional reasoning, 
selective attention to threat, interpretive and expectancy 
biases, physiological anticipation of threat, avoidance of 
threat, etc.), and the shared general biological vulnera-
bility factor (negative affect or neuroticism), suggest 
that a “transdiagnostic” approach could be more appro-
priate than a disorder-specifi c perspective (Belloch, 
2012; Craske, 2012; Harvey, 2004; McManus et al., 
2010; Sandín, Chorot, & Valiente, 2012). A transdiag-
nostic process has been defi ned as “a major factor that 
can explain the maintenance of numerous disorders that 
an individual may experience” (Egan, Wade, & Shafran, 
2012). In a similar vein, transdiagnostic treatments are 
“those that apply the same underlying treatment princi-
ples across mental disorders without tailoring the proto-
col to specifi c diagnoses” (McEvoy, Nathan, & Norton, 
2009). Thus, in contrast with disorder-specifi c CBT, 
transdiagnostic cognitive-behavioral therapy (T-CBT) 
 Revista de Psicopatología y Psicología Clínica 2016, Vol. 21 (3), 147-175
 T-CBT in adults, children and adolescents  149
could be defi ned as a CBT therapy that is applied to a 
number of different specifi c disorders that share com-
monalities in cognitive, behavioral, and/or emotional ar-
eas of dysregulation (Sandín et al., 2012). Several cogni-
tive and behavioral variables have been proposed as 
possible transdiagnostic concepts and processes 
 (Belloch, 2012; Harvey, 2004; Sandín et al., 2012). For 
example, Harvey (Harvey, 2004) categorized 14 transdiag-
nostic processes within the broad domains of attention 
(e.g., selective attention), memory (e.g., recurrent mem-
ories), reasoning (e.g., expectancy bias), thought (e.g., 
thought suppression), and behavior (e.g., avoidance). 
Other proposed transdiagnostic constructs include nega-
tive affectivity/neuroticism, emotion regulation strate-
gies, distress tolerance, perfectionism, anxiety sensitivi-
ty, disgust sensitivity, thought-action fusion, intolerance 
of uncertainty, self-esteem, alexithymia, and anhedonia 
(Aldao, 2012; Egan et al., 2012; Belloch, 2012; Sandín 
et al., 2012). 
A conceptual and CBT transdiagnostic approach was 
fi rst developed by Fairburn, Cooper, and Shafran (2003). 
These authors described a transdiagnostic model fo-
cused on eating disorders and suggested that common 
mechanisms (e.g., over-evaluation of eating, perfection-
ism, mood intolerance, low self-esteem) are involved in 
the maintenance of eating disorders (bulimia nervosa, 
anorexia nervosa, and atypical eating disorders). On the 
basis of this transdiagnostic model, they developed a 
transdiagnostic CBT for eating disorders. The primary 
characteristics of this new CBT approach are that the 
treatment was designed to be suitable for all forms of 
eating disorders and patients’ specifi c eating disorder is 
not of relevance to the treatment. This line of research 
was advanced by Barlow, Allen and Choate (2004) for 
emotional disorders, providing a transdiagnostic theoret-
ical model and a unifi ed (transdiagnostic) treatment for 
these disorders. These authors proposed the rationale for 
a “unifi ed treatment” of emotional disorders based on 
the following three fundamental therapeutic compo-
nents: (a) altering antecedent cognitive reappraisals (of 
both internal and external threat and danger), (b) pre-
venting emotional avoidance (cognitive and behavioral 
avoidance strategies, such as emotion suppression, wor-
ry, distraction, interoceptive and exteroceptive avoid-
ance), and (c) modifying action tendencies (emotion-in-
ducing exposure-based procedures). 
Based on this theoretical shift toward a transdiagnos-
tic conceptualization of emotional disorders, several 
transdiagnostic CBT protocols have been created for 
anxiety and depressive disorders by independent re-
search groups (for a review, see Norton & Paulus, 2015). 
The Unifi ed Protocol for Transdiagnostic Treatment of 
Emotional Disorders (UP), developed by Barlow’s group 
(Barlow et al., 2011; Farchione et al., 2012), is a transdi-
agnostic emotion-focused CBT which, while it under-
scores the fundamental principles of traditional CBT, 
emphasizes the ways individuals with anxiety or depres-
sive disorders experience and respond to their emotions 
(emotion regulation). The eight modules of the protocol 
are typically delivered in no more than eighteen 60-
minute individual treatment sessions. It includes fi ve 
core modules designed to target key aspects of emotional 
processing and regulation of emotional experiences: 
(a) increasing present-focused emotional awareness, (b) 
increasing cognitive flexibility, (c) identifying and 
preventing patterns of emotion avoidance and maladap-
tive emotion-driven behaviors, (d) increasing awareness 
and tolerance of emotion-related physical sensations, 
and (e) interoceptive and situation-based emotion-fo-
cused exposure. Though the UP was designed to be de-
livered as an individual treatment, recently it has also 
been adapted to a group format (Bullis et al., 2015; De 
Ornelas Maia, Braga, Nunes, Nardi, & Silva, 2013).
Another established transdiagnostic CBT program 
for emotional disorders, developed by Norton (2012a), 
is the Transdiagnostic Group Cognitive-Behavioral 
Therapy for Anxiety (T-GCBT). It consists of twelve 
2-hour weekly sessions in groups of six to eight individ-
uals with any anxiety disorder diagnosis. Treatment em-
phasizes the excessive or irrational fear of a particular 
thing (negative evaluation, somatic symptoms, etc.) as 
opposed to having a particular diagnosis (e.g., panic dis-
order), so that patients are seen as sharing the same basic 
pathology, even though the specifi c stimuli that trigger 
the fear/anxiety and the associated behavioral responses 
may differ. The T-GCBT includes psychoeducation, cog-
nitive restructuring, graduated in-session exposure and 
response prevention, cognitive restructuring of core be-
liefs, and relapse prevention. 
These two transdiagnostic CBT treatments of emo-
tional disorders have shown initial effi cacy in treating 
anxiety and depressive disorders (Norton, 2012b; Norton 
& Paulus, 2015; Reinholt & Krogh, 2014). In contrast 
with disorder-specifi c CBT, they target common psycho-
pathological processes and use generic CBT components 
to change them. Although internet-delivered treatment 
for emotional disorders have been suggested as a new de-
velopment in clinical psychology (Andersson, Nordgren, 
Buhrman, & Carlbring, 2014; Cuijpers & Riper, 2014), 
both transdiagnostic treatments use a traditional face-to-
face format. However, a transdiagnostic internet-based 
CBT treatment (T-iCBT) was recently developed by 
Titov’s group (Titov, Dear, Johnston, & Terides, 2012). This 
T-iCBT includes separate programs to treat anxiety (the 
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Anxiety Program) and anxiety and depression (the Well-
being Program). It consists of eight core online lessons 
(each requiring no more than 20 minutes of reading), 
which participants are asked to complete over ten weeks. 
The Wellbeing Program differs from the Anxiety Program 
by including education and guidelines regarding behavioral 
activation. The T-iCBT targets maladaptive cognitions 
(thoughts and beliefs) and behaviors (avoidance, safety 
behaviors, and underactivity) as well as physical symp-
toms (hyper-arousal or hypo-arousal). It is based on the 
main components of CBT but also incorporates therapeu-
tic components of interpersonal therapy. The effi cacy of 
the T-iCBT approach to reduce comorbid symptoms of 
anxiety and depression has been documented through a 
number of trials (Dear et al., 2011; Johnston, Titov, An-
drews, Spence, & Dear, 2011; Titov et al., 2013; Titov, 
Andrews, Johnston, Robinson, & Spence, 2010; Titov et 
al., 2011), including several trials in primary care settings 
(Newby et al., 2013; Newby, Mewton, Williams, & An-
drews, 2014). Drawing from Barlow’s UP, Botella’s group 
developed a new T-iCBT protocol (i.e., the EmotionReg-
ulation program) designed to the treatment of emotional 
disorders in adults (anxiety disorders, unipolar mood dis-
orders, and obsessive-compulsive disorder) (González-Ro-
bles et al., 2015). 
A promising line of research concerns the develop-
ment or adaptation of transdiagnostic programs to be ap-
plied to children and adolescents. Although most chil-
dren/adolescents who are referred for treatment due to 
emotional problems show high rates of diagnostic comor-
bidity, evidence-based treatment approaches in this popu-
lation have typically been disorder-specifi c. However re-
cently, drawing from research with the UP in adult 
samples (Barlow et al., 2011; Davis, Barlow, & Smith, 
2010; Ellard, Fairholme, Boisseau, Farchione, & Barlow, 
2010), Ehrenreich-May’s team (Ehrenreich-May et al., 
2012; Ehrenreich-May & Chu, 2014), developed two 
transdiagnostic unifi ed protocols for treatment of anxiety 
and depression in adolescents (the Unifi ed Protocol for 
the Treatment of Emotional Disorders in Adolescents; UP-
A) and children (the Unifi ed Protocol for the Treatment of 
Emotional Disorders in Chidren; UP-C) (Ehrenreich-May 
et al., 2016). The UP-A is a downward extension of the 
UP for adolescents (ages 12-17) with a principal anxiety 
or depressive disorder. It consists of eight core treatment 
modules and was designed to be delivered within 8 to 21 
weekly individual sessions. The UP-C is a downward ex-
tension of the UP for younger children (ages 7-12) with 
anxiety disorders and consists of 15 weekly 90-minute 
group sessions. Preliminary data suggest that both proto-
cols are effective in reduction of principal and overall emo-
tional diagnosis severity (Ehrenreich-May et al., 2012).
Other transdiagnostic CBT protocols for emotional 
disorders (anxiety and depression) in children or adoles-
cents have been developed recently. However, they are 
less established than the UP-A and UP-C: ED and/or are 
more directed towards preventive goals. Weersing and 
colleagues created the Integrated Brief Behavioral Ther-
apy for Anxiety and Depression (Weersing, Gonzalez, 
Campo, & Lucas, 2008; Weersing, Rozenman, Ma-
her-Bridge, & Campo, 2012), a brief transdiagnostic 
treatment for anxiety and depression for implementation 
in the primary care setting. Additionally, Chu and col-
leagues designed the Transdiagnostic Group Behavioral 
Activation Therapy (GBAT) to treat adolescents diag-
nosed with depression, anxiety, or both within a school 
setting (Chu, Colognori, Weissman, & Bannon, 2009). 
The Group Behavior Activation Therapy for Bullying 
(GBAT-B) is being developed to address anxiety and 
mood problems secondary to bullying (Chu, Johns, & 
Hoffman, 2015; Chu, Hoffman, Johns, Reyes-Portillo, & 
Hansford, 2014). In the prevention area, EMOTION: 
“Coping Kids” Managing Anxiety and Depression is a 
transdiagnostic intervention aimed to reduce the likeli-
hood of an anxiety and/or depressive disorder (Kendall, 
Stark, Martinsen, O’Neil, & Arora, 2013). Finally, Essau 
and colleagues examined the effectiveness of a transdi-
agnostic anxiety disorder prevention protocol, Super 
Skills for Life (Essau & Ollendick, 2013; Essau, Lewin-
sohn, Olaya, & Seeley, 2014). 
It has been suggested that, compared to disorder-spe-
cifi c CBT, T-CBT protocols have a number of practical 
advantages, including better access to the health care 
system (availability, primary care, prevention, etc.) and 
an improved approach to comorbidity (Clark, 2009). In 
general, transdiagnostic interventions provide a more ef-
fi cient and cost-effective model both for practitioners 
and for patients (Bullis et al., 2015). In the last few years, 
new research has emerged on the effi cacy of T-CBT. 
Apart from certain systematic reviews (McEvoy et al., 
2009; McManus et al., 2010), a few recent meta-analy-
ses have examined the effectiveness of T-CBT for emo-
tional disorders. Three of these examined the effi cacy of 
T-CBT in adult samples focusing on anxiety (Norton & 
Philipp, 2008; Reinholt & Krogh, 2014) or on anxiety 
and depression (Newby, McKinnon, Kuyken, Gilbody, & 
Dalgleish, 2015). Only one meta-analysis on T-CBT for 
young people has been published (Ewing, Monsen, 
Thompson, Cartwright-Hatton, & Field, 2015), and it 
only dealt with anxiety. In general, these meta-analyses 
provide preliminary information in support of the effec-
tiveness of T-CBT for emotional disorders. However, 
these studies have some limitations that make it diffi cult 
to draw clear conclusions on the effi cacy of T-CBT for 
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the treatment of emotional disorders (anxiety and de-
pressive disorders). 
There are several reasons why a new meta-analysis is 
necessary at this point. The fi rst, and perhaps the most 
signifi cant, is that a number of relevant studies investi-
gating the effi cacy of T-CBT protocols for anxiety and 
depression disorders have been published in the last two 
years, yet some of them are not included in these me-
ta-analyses. Second, the most recent meta-analysis 
(Newby et al., 2015) mixed studies with no CBT-based 
treatment protocols, such as mindfulness therapy, psy-
chodynamic psychotherapy, and acceptance and com-
mitment therapy. Third, all of these previous reviews in-
corporated a number of studies that did not used 
theory-based transdiagnostic CBT protocols (i.e., T-CBT 
protocols designed to address underlying mechanisms 
shared by a group of disorders) such as classical CBT 
applied to several specifi c anxiety disorders, hybrid pro-
tocols (transdiagnostic/disorder-specifi c protocols), tai-
lored treatments (i.e., treatments adapted to the patients’ 
specifi c diagnoses), or modular approaches. Fourth, the 
previous meta-analyses did not take into account the pre- 
and post-treatment data when calculating the randomized 
controlled trial (RCT) effect size. Finally, most of the 
published T-CBT meta-analyses (e.g., Ewing et al., 2015; 
Reinholt & Krogh, 2014) only focused on anxiety disor-
ders. These problems make it diffi cult to draw valid con-
clusions about the effi cacy of T-CBT for the treatment of 
emotional disorders.
The present meta-analysis aimed to test the hypothe-
sis that T-CBT is an effective treatment for reducing 
symptoms of anxiety and depression in adults and youths 
with principal or comorbid anxiety and/or depressive dis-
orders, or subthreshold anxiety or depression. Moreover, 
we aimed to explore the impact of potential moderators 
of treatment effect, including participants’ primary char-
acteristics, diagnostic measures, and delivery format.
Thus far, this is the fi rst meta-analysis to examine the 
effi cacy of transdiagnostic CBT protocols explicitly 
based in the transdiagnostic theory-driven approach, to 
include studies conducted with both adult and children/
adolescent samples, and to use a more complete Hedges 
g’s formula to calculate the effect size of RCT, taking 
into account pre- and post-treatment data.
Method
Protocol and registration
This review was developed following the procedures 
outlined in the Cochrane Handbook for systematic re-
views (Higgins & Green, 2011) and it is reported follow-
ing the PRISMA guidelines (Moher, Liberati, Tetzlaff, & 
Altman, 2009). 
Eligibility criteria 
Types of participants. We included patients with a 
primary diagnosis of an anxiety and/or a depressive dis-
order, or with subclinical anxiety and/or depression 
symptoms. In order to encompass studies conducted 
prior to the development of DSM-5, we decided to include 
patients with PTSD, acute stress disorder (ASD), and 
obsessive compulsive disorder (OCD).
Types of interventions. We included studies that ap-
plied theory-driven T-CBT protocols (i.e., protocols de-
signed to target common mechanisms or processes that 
occur across a group of disorders) to treat multiple anx-
iety and/or depressive disorders, without tailoring the 
protocol to specifi c diagnoses (i.e., the same interven-
tion was delivered for all of the subjects). Studies that 
delivered treatment in an individual, group, or internet/
computer-based format were included.
Types of comparisons. RCTs were included in which 
the effects of transdiagnostic treatment were compared 
with: (a) a waiting list control (WLC) condition, (b) an 
attention control condition (e.g., discussion group), and 
(c) other therapies (e.g., disorder-specifi c CBT). We did 
not exclude uncontrolled studies since a high proportion 
of the published studies on T-CBT are uncontrolled; we 
conducted separate analyses for the RCTs and the un-
controlled studies.
Types of outcomes: Studies were included if at least 
one self-reported measure of anxiety or anxiety and de-
pression was administered at both baseline and 
post-treatment 1. We were also interested in examining 
outcomes at follow up. 
Types of study design. RCTs or uncontrolled studies 
were used if they (a) had at least fi ve participants in the 
T-CBT condition at pretreatment, (b) were written in 
English or in Spanish, (c) were published in a peer-re-
viewed journal, and (d) provided the necessary statistical 
data to calculate the effect size. 
Exclusion criteria 
Studies were excluded if they (a) used alternative 
therapies to CBT, (b) used any form of protocol tailored 
to the treatment of any specifi c disorder, (c) included a 
psychological treatment that was combined with drug 
1 The studies of Norton (2012) and Norton & Barrera (2012) did not 
report pre-treatment data, but we contacted the fi rst author and were able 
to obtain all the data needed. 
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therapy, (e) included patients with psychotic disorders, 
personality disorders, or substance use disorders, or (f) 
included case studies.
Information sources and search
The studies were traced in several ways. First, 
comprehensive searches were undertaken in the 
databases Scopus, PsycINFO, Science Direct, 
PsycArticles, and Google Scholar using the search string 
“(transdiagnostic AND anxiety OR depression OR 
emotional disorder OR depressive disorder OR mood 
disorder OR anxiety disorder OR internalizing OR 
negative affectivity)” in keywords, titles and abstracts. 
Second, the references of the systematic reviews and 
meta-analysis on T-CBT published to date were reviewed. 
Third, a search of the reference sections of the retrieved 
papers was conducted to identify additional studies. The 
main search for studies was completed in July 2015 and 
was last updated in March 2016. 
Study selection 
Those abstracts clearly irrelevant for the current 
study were discarded, while the remaining full texts were 
reviewed to assess whether they met the inclusion 
criteria. 
Data collection process and data items
A range of study characteristics were coded and ex-
tracted from each study: study type (RCT/uncontrolled), 
control condition if existent, sample size, publication 
date, country, percentage of attrition, risk of bias, diag-
nostic measure applied, sample recruitment (community/
clinical) and follow-up period. With regard to inter-
vention characteristics, application format (group/
individual/ internet), treatment target (anxiety and/ or 
depression), and total number of sessions were coded 
and extracted. Participant characteristics studied were 
as follows: age group (adults/children-adolescents), 
mean age, gender, inclusion or exclusion of subclinical 
patients, and primary mental disorder.
Risk of bias in individual studies
An assessment of the studies’ methodological quality 
was undertaken as previous studies have shown that a 
high risk of bias tends to overestimate the treatment ef-
fect size (Savović et al., 2012). The Cochrane Collabora-
tion’s tool for assessing risk of bias was used (Higgins & 
Green, 2011), although minor adaptations of the tool 
were made in order to be able to assess psychotherapy 
studies. Performance bias was not coded since it is not 
feasible to blind therapists and clients to a psychothera-
peutic intervention. The main domains assessed included 
selection bias, detection bias, attrition bias, reporting 
bias and “other biases.” In uncontrolled trials, attrition 
bias, reporting bias, and other biases were the only 
domains coded. A judgment of low risk, unclear, or high 
risk of bias was given within each domain (Table 2).
Summary measures
An a priori decision was made to calculate an effect 
size for anxiety in those studies that included patients 
with principal or comorbid anxiety disorders and another 
effect size for depression in those studies that included 
patients with principal or comorbid depressive disor-
ders. Except for 6 studies that only reported the changes 
in anxiety (Essau et al., 2014; Norton, 2008; Norton & 
Barrera, 2012; Norton, 2012b; Titov et al., 2010 [1&2]), 
effect sizes for both anxiety and depression outcomes 
were calculated in all studies. The measures chosen to 
calculate the effect sizes were the ones present to a greater 
extent in the majority of included studies (Table 1), and 
most of the times were the ones defi ned by the studies’ 
authors as principal outcome measures. The formulas for 
Hedges’ g and it’s standard deviation, specifi cally the 
formulas (1) and (2) (Botella & Sanchez-Meca, 2015), 
were used. In the case of the RCTs, we chose a complete 
non-biased estimator of g with a mean weighted standard 
deviation considering control and experimental groups 
because these groups are matched at pre-test in the 
majority of original studies. This equation also corrects 
the effect that other factors could have had on the control 
group and uses the descriptive statistics usually reported 
in the assessed literature.
Like Cohen’s d, Hedges’ g is based on the standard-
ized mean difference and effect sizes of 0.2, 0.5, and 0.8 
are considered small, medium, and large, respectively 
(Cohen, 1992). 
(1)
(1) Standardized mean change index (Hedges’g) used for 
uncontrolled studies and its standard deviation. k = sample bias 
correcting factor; n = sample size; g = Hedges’g; X = mean; Pre = 
pre-treatment; Post = post-treatment; SD = standard deviation; 
SD
g
 = Hedge’s g standard deviation.
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(2)
(2) Standardized mean change index (Hedges’g) used for RCTs 
and its standard deviation. k = sample bias correcting factor; 
n = sample size; C = control; T = treatment; g = Hedges’g; 
X = mean; Pre = pre-treatment; Post = post-treatment; SD = standard 
deviation; SD
g
 = Hedge’s g standard deviation. 
Synthesis of results, risk of bias and additional analysis 
The software program, Comprehensive Meta-analysis 
(2.2) was employed to conduct all the statistical analysis. 
Because of the variations in methods and samples of the 
studies, a random effects model was used. The analyses 
were based on intent-to-treat data to the extent possible. 
For each comparison between a psychotherapy group 
and a comparison group, the effect size indicating the 
difference between the two groups at pre- and post-
treatment was calculated. When possible, the effect sizes 
for pre-treatment to follow-up changes were also 
computed. The degree of heterogeneity was examined 
using the Cochrane´s Q statistic and the I2 index (Higgins 
& Thompson, 2002). Heterogeneity refers to substantial 
differences in effect sizes between studies that are due to 
between-trial differences rather than to chance. The I2 
statistic is a quantifi cation of this heterogeneity with 
25%, 50% and 75% refl ecting respectively low, medium, 
and high heterogeneity (Higgins, Thompson, Deeks, & 
Altman, 2003).
Publication bias was tested using Duval and Tweedie’s 
trim-and-fi ll procedure (Duval & Tweedie, 2000) within 
the comprehensive meta-analysis. The Tweedie’s trim-
and-fi ll test provides an adjusted effect size correcting 
for publication bias.
Finally, subgroup analyses were conducted in order 
to assess possible variations in the effect sizes. A random 
effects model was used to combine studies within each 
subgroup. A fi xed effects model was used to combine 
subgroups and yield the overall effect. The between-study 
variance (tau-squared) was assumed to be the same for 
all subgroups. 
Results
Study selection and characteristics
The inclusion of studies process is summarized in 
Figure 1. The search yielded 1519 hits. A total of 48 
studies (included in 41 publications ) met our inclusion 
criteria (21 RCTs, 27 uncontrolled studies; 43 adult 
samples; 5 child/adolescent samples). The 48 studies in-
340 of full-text articles excluded, with reasons:
Theoretical articles on transdiagnostic treatment or factors (n=112)
Not CBT transdiagnostic treatment (n=115)
Sample with excluded diagnosis (e.g., eating disorders) (n=35)
Case studies or other excluded study designs (n=36)
Individually tailored treatments (n=34)
Prevention or maintaining therapy studies (n=3)
Secondary analysis of RCTs (n=3)
Not enough data to calculate effect size (n=2)
1519 of records identifi ed 
through database searching 
81 of additional records identifi ed through 
other sources 
Figure 1. Study fl ow diagram. 
1297 of records after 
duplicates removed 
48 studies (included in 
41 articles) included in 
quantitative synthesis 
(meta-analysis)
381 of full-text articles 
assessed for eligibility
1297 of records screened 916 of records excluded
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vestigated 22 different transdiagnostic protocols. Con-
cerning the 21 included RCTs, 20 studied adults whereas 
only 1 (Chu et al., 2016), which used WLC, included 
participants younger than 18 years of age. Out of the 20 
RCTs with adults, 13 studies involved WLC (Bolton et 
al., 2014; Chu et al., 2016; Farchione et al., 2012; John-
ston et al., 2011; Mullin et al., 2015; Newby et al., 2013 
(1); Norton, Hayes, & Hope, 2004; Norton & Hope, 
2005; Schmidt et al., 2012; Titov et al., 2013; Titov et al., 
2010 (1); Titov et al., 2011; Wuthrich & Rapee, 2013), 
one study used a discussion group for comparison 
(Wuthrich, Rapee, Kangas, & Perini, 2016), one used 
TAU for comparison (Ejeby et al., 2014), one used 
relaxation training (Norton, 2012b), and fi ve studies 
compared T-CBT with disorder-specifi c CBT (Dear et 
al., 2015; Fogliati et al., 2016; Lotfi , Bakhtiyari, As-
gharnezhad-Farid, & Amini, 2014; Norton & Barrera, 
2012; Titov et al., 2015b). The study characteristics can 
be found in Table 1.
Participants
The sample for this meta-analysis totaled 6291 
participants. There was a greater representation of 
females than males across studies, with the overall 
percentage of females being 61.02 (SD = 15.55). 
Participants were on average 41.14 (SD = 12.04) years 
old in the studies including an adult sample and 11.78 
(SD = 2.60) years in the ones including children and 
adolescents. In relation to the recruitment method, 
patients were recruited from clinical samples in seven 
studies (all of them including adults), while in the rest 
of the studies patients were recruited, at least partly, 
through community referrals. A total of 45 studies 
included data on the percentage of participants who 
discontinued treatment (attrition). The attrition 
percentage was on average 23.10 (SD = 15.97). 
Treatments
Of the 48 included studies, 13 evaluated protocols 
designed to treat mainly anxiety disorders while 33 were 
intended to treat both anxiety and depressive disorders 
(Table 1). However, as stated in the methods section, all 
studies that included patients with depressive symptoms 
and reported pre- to posttreatment depression outcomes 
were included in the depression outcomes’ analyses. The 
duration of the treatment in the included studies ranged 
from 4 to 18 sessions, with an average of 9.14 sessions 
(SD = 3.99). In 22 studies the treatment was delivered 
over the Internet; in the remaining 26 it was delivered 
face to face (in 17 studies in a group format, whereas in 9 
in an individual format). The bulk of the studies (23) 
were conducted in Australia, followed by 18 in the US, 3 
in England, 1 in Iran, 1 in Brazil, 1 in Japan, and 1 in 
Sweden. In relation to the treatment components, all 
studies included psychoeducation and relapse prevention. 
Exposure was included in all studies except for the one by 
Essau and colleagues (Essau et al., 2014); cognitive 
restructuring was present in all studies except for those 
by Chu and colleagues (Chu et al., 2009; Chu et al., 
2016). Additionally, behavioral activation was included 
in 33 studies 2, problem solving in 25 studies 3, and 
relaxation strategies in 29 studies 4. Response prevention 
was included in 15 studies 5, and mindfulness was 
included in 7 studies 6. The studies tested 22 different 
transdiagnostic protocols. The most common ones were 
the Unifi ed Protocol (present in 6 studies), the Wellbeing 
Course (present in 9 studies), with their different 
variations, and the Transdiagnostic-Group CBT (present 
in 5 studies) (see Table 1). 
Risk of bias within studies 
Table 2 provides an overview of the potential biases 
of the studies. The RCTs (21 studies) were assessed in 6 
categories whereas the uncontrolled studies (27 studies) 
were only assessed in 3 categories. Taking into account 
only the RCTs, 11 studies (52.38%) reported low risk of 
2 Behavioral activation not included in: Bullis et al., 2015; De Or-
nelas Maia et al., 2013; Ellard et al., 2010 (1&2); Espejo et al., 2016; 
Farchione et al., 2012; Lotfi  et al., 2014; Norton et al., 2004; Norton & 
Hope, 2005; Norton, 2008; Norton & Barrera, 2012; Norton, 2012b; 
Schmidt et al., 2012; Titov et al., 2010 (1&2).
3 Problem solving was included in: Bilek & Ehrenreich-May, 2012; 
Chu et al., 2009; Chu et al., 2016; De Ornelas Maia et al., 2013; Dear et 
al., 2015; Dear et al., 2011; Essau et al., 2014; Fogliati et al., 2016; Kay-
rouz et al., 2015; Kayrouz et al., 2016; Kirkpatrick, Manoukian, Dear, 
Johnston, & Titov, 2013; Mullin et al., 2015; Newby et al., 2013 (1&2); 
Newby et al., 2014; Queen, Barlow, & Ehrenreich-May, 2014; Titov et al., 
2013; Titov et al., 2015a (1&2); Titov et al., 2016 (1, 2, & 3); Titov et al., 
2015b; Wuthrich et al., 2016; Wuthrich & Rapee, 2013.
4 Relaxation not included in: Bilek & Ehrenreich-May, 2012; Bullis 
et al., 2015; Chu et al., 2009; Chu et al., 2016; Ejeby et al., 2014; Ellard et 
al., 2010 (1&2); Espejo et al., 2016; Farchione et al., 2012; Gros, 2014 (1); 
Lotfi  et al., 2014; McEvoy & Nathan, 2007; Newby et al., 2014; Norton, 
2008; Norton & Barrera, 2012; Norton, 2012b; Schmidt et al., 2012; 
Wuthrich et al., 2016; Wuthrich & Rapee, 2013.
5 Response prevention included in: Bilek & Ehrenreich-May, 2012; 
Bullis et al., 2015; De Ornelas Maia et al., 2013; Ellard et al., 2010 (1&2); 
Espejo et al., 2016; Farchione et al., 2012; Gros, 2014 (2); Ito et al., 2016; 
Lotfi  et al., 2014; Norton et al., 2004; Norton & Hope, 2005; Norton, 
2008; Queen et al., 2014; Schmidt et al., 2012. 
6 Mindfulnes included in: Bullis et al., 2015; De Ornelas Maia et al., 
2013; Ellard et al., 2010 (1&2); Farchione et al., 2012; Ito et al., 2016; 
Queen et al., 2014. 
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Table 1. Characteristics of included studies evaluating transdiagnostic cognitive behavior therapy treatments for anxiety and/or depression
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Table 1. Characteristics of included studies evaluating transdiagnostic cognitive behavior therapy treatments for anxiety and/or 
depression (continuation)
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Table 1. Characteristics of included studies evaluating transdiagnostic cognitive behavior therapy treatments for anxiety and/or 
depression (continuation)
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Table 1. Characteristics of included studies evaluating transdiagnostic cognitive behavior therapy treatments for anxiety and/or 
depression (continuation)
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T-iCBT: 5 lessons/ 8 
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ANX or DEP 
T-iCBT: 5 lessons/ 8 





















T-iCBT: 5 lessons/ 8 





















T-iCBT: 5 lessons/ 8 



















criteria for an 
anxiety and 
mood disorder 
T-GCBT: 12 x 2h 




GAD 34.6; MDD 20.6; 
DYS 14.1; MDNOS 10.3; 
Soc. P 10.3; PTSD 4.4; SP 















ANX and a 
unipolar mood 
disorder
T-GCBT: 11 x 2h 
sessions; (Ageing 




GAD 33.1; MDD 27.8 








Note. ADIS-IV = Anxiety Disorders Interview Schedule for DSM-IV; ADIS-IV-C = Anxiety Disorders Interview Schedule for DSM-IV-Child Interview; ADIS-IV-C/P = Anxiety Disorders Interview Schedule for 
DSM-IV-Child and Parent Reports; ADIS-IV-L= Anxiety Disorders Interview Schedule for DSM-IV-Lifetime Version; ADNOS = Anxiety disorder not otherwise specifi ed; ANX = anxiety; BAI = Beck Anxiety 
Inventory; BDI = Beck Depression Inventory; BDI-II = Beck Depression Inventory, second edition; CBT = cognitive behavior therapy; CESD-CP = Center for Epidemiologic Studies Depression Scale for Chil-
dren-Child and Parent reports; CETA = Common Elements Treatment Approach; Clin = clinical recruitment; Com = at least in part recruitment through the community; CPRS-S-A = Self-Rating Scale for Affective 
Syndroms (Anxiety); CPRS-S-D = Self-Rating Scale for Affective Syndroms (Depression); DASS = Depression Anxiety Stress Scales 21-Item Version; DEP = depression; DG = discussion group; DS-GCBT = 
group-delivered disorder specifi c cognitive behavior therapy; DS-iCBT = internet-delivered disorder specifi c cognitive behavior therapy; DYS = dystimia; F-SET = False Safety Behavior Elimination Therapy; 
GAD = generalized anxiety disorder; GAD-7 = Generalized Anxiety Disorder-7 item Scale; GAI = Geriatric Anxiety Inventory; GBAT = Group Behavioral Activation Therapy; GDS = Geriatric Depression Scale; 
GPs = general practitioners; HSCL-25 = Hopkins Symptom Checklist 25; HTQ = Harvard Trauma Questionnaire; iCBT = internet-delivered cognitive behavioral therapy; MASC-CP = Multidimensional Anxiety 
Scale for Children-Child and Parent reports; MDD = major depressive disorder; MDNOS = Mood Disorder Not Otherwise Specifi ed; MINI = Mini International Neuropsychiatric Interview version 5.0.0; Mi-
ni-MASQ = The Mini Mood and Anxiety Symptom Questionnaire; MINI-SPIN = MINI Social Phobia Inventory; MINI-t = Mini International Neuropsychiatric Interview version 5.0.0 conducted through telephone; 
NR = not reported; PTSS = post-traumatic stress symptoms; OASIS = Overall Anxiety Severity and Impairment Scale; OCD = obsessive compulsive disorder; ODSIS = Overall Depression Severity and Impairment 
Scale; Pan/Ag = panic disorder with or without agoraphobia; PDSS = Panic Disorder Severity Scale; PHQ-9 = Patient Health Questionnaire- 9 item; PTSD = posttraumatic stress disorder; RCADS = Revised Chil-
dren’s Anxiety and Depression Scale; RCT = randomized controlled trial; RLX = relaxation training program; SAD = social anxiety disorder; SCARED = Screen for Child anxiety Related Emotional Disorders–
Child and Parent Reports; SCAS = Spence Children’s anxiety Scale; SCID-IV = Structured Clinical Interview for Axis I DSM-IV Disorders; SD = Separation Disorder; Soc.P = social phobia; SP = specifi c phobia; 
STAI = State-Trait Anxiety Inventory; TAU = Treatment As Usual; T-CBT = Transdiagnostic Behavior Therapy; T-GCBT = group- delivered transdiagnostic cognitive behavior therapy; T-iCBT = internet-delivered 
transdiagnostic cognitive behavior therapy; UK = United Kingdom; UP = Unifi ed Protocol; UP-A = Unifi ed Protocol for the Treatment of Emotional Disorders in Adolescence; UP-C = Unifi ed Protocol for the 
Treatment of Emotional Disorders in Children; USA = United States of America; WLC = waiting list control. 
a Recruitment method; b Taking into account the overall sample; c Number of participants included in the fi nal analysis of the study and used in our meta-analysis; d Follow up is in months; e Not included in the study (---)
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Table 2. Risk of bias in the included studies
Selection bias Detection bias Attrition bias Reporting bias Other bias












T-CBT vs. Controls 
Bolton et al., 2014 Low Low High Low Unclear Low
Farchione et al., 2012 High High High Low Unclear Low
Johnston et al., 2011 Low Unclear High High Unclear Low
Mullin et al., 2015 Unclear Unclear High Low Unclear Low
Newby et al., 2013 (1) Low Low High Low Unclear Low
Norton et al., 2004 Unclear Unclear High High Unclear Low
Norton & Hope, 2005 Unclear Unclear High High Unclear Low
Schmidt et al., 2012 Low Low High Low Unclear Low
Titov et al., 2010 (1) Low Unclear High High Unclear Low
Titov et al., 2011 Low Unclear High High Unclear Low
Titov et al., 2013 Low Unclear High Low Unclear Low
Wutrich & Rapee, 2013 Low Low High Low Unclear Low
Wutrich et al., 2016 Low Unclear High Low Unclear Low
Uncontrolled T-CBT
Bullis et al., 2015 --- --- --- Unclear Unclear Low
Dear et al., 2011 --- --- --- Low Unclear Low
De Ornelas et al., 2013 --- --- --- Unclear Unclear Low
Ellard et al., 2010 (1) --- --- --- Unclear Unclear Low
Ellard et al., 2010 (2) --- --- --- High Unclear Low
Espejo et al., 2016 --- --- --- High Unclear Low
Gros, 2014 (1) --- --- --- High Unclear Low
Gros, 2014 (2) --- --- --- High Unclear Low
Ito et al., 2016 --- --- --- Low Unclear Low
Johnston et al., 2014 --- --- --- Low Unclear Low
Kayrouz et al., 2015 --- --- --- Low Unclear Low
Kayrouz et al., 2016 --- --- --- Low Unclear Low
Kirpatrick et al., 2013 --- --- --- Low Unclear Low
McEvoy & Nathan, 2007 --- --- --- High Unclear Low
Newby et al., 2013 (2) --- --- --- Low Unclear Low
Newby et al., 2014 --- --- --- Low Unclear Low
Norton, 2008 --- --- --- Low Unclear Low
Titov et al., 2010 (2) --- --- --- High Unclear Low
Titov et al., 2015a (1) --- --- --- Unclear Unclear Low
Titov et al., 2015a (2) --- --- --- Unclear Unclear Low
Titov et al., 2016 (1) --- --- --- Low Unclear Low
Titov et al., 2016 (2) --- --- --- Low Unclear Low
Titov et al., 2016 (3) --- --- --- Low Unclear Low
T-CBT vs other therapies 
Dear et al., 2015 Low Low High Low Unclear Low
Ejeby et al., 2014 Unclear Low High Low Unclear Low
Fogliati et al., 2016 Unclear Unclear High Low Unclear Low
Lotfi  et al., 2014 Unclear Unclear High High Unclear Low
Norton, 2012b Unclear Unclear High High Unclear Low
Norton & Barrera, 2012 Unclear Unclear High Low Unclear Low
Titov et al., 2015b Unclear Unclear High Low Unclear Low
Children and adolescents
Bilek & Ehrenreich, 2012 --- --- --- High Unclear Low
Chu et al., 2009 --- --- --- Low Unclear Low
Chu et al., 2016 Low Unclear High Low Unclear Low
Essau et al., 2014 --- --- --- High Unclear Low
Queen et al., 2014 --- --- --- Unclear Unclear Low
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bias on random sequence generation, 6 studies (28.57%) 
were assessed with low risk of bias on allocation con-
cealment, and all RCTs reported high risk of bias on 
blinding of outcome assessment, since in all cases 
self-report outcome measures were used for the analy-
ses. Taking into account all 48 studies, both RCTs and 
uncontrolled studies, 27 (56.25%) reported low risk of 
bias on handling incomplete outcome data, whereas all 
studies were assessed as having unclear bias on selective 
reporting. Finally, all studies reported low risk of bias in 
the other sources of bias categories. 
Results of individual studies 
Figures 2 to 9 show the effect size (Hedge’s g), with 
its standard error, variance, confi dence interval, z-value 
and p-value for each study on the considered outcomes 
(anxiety and depression). 
Synthesis of results
Below, we report the results of the 10 meta-analyses con-
ducted after grouping the studies according to the age 
sample (adults vs. youth), the existence of a control group 
(RCTs vs. uncontrolled), the type of control group (WLC or 
other therapies), and the outcome (anxiety vs. depression). 
a) Pre- to post- meta-analytic anxiety outcomes in 
adult–RCTs (Fig. 2). Of the 12 studies included, 10 re-
ported a signifi cant reduction in self-reported anxiety (p < 
.05), whereas 2 studies did not (Farchione et al., 2012; 
Wuthrich et al., 2016). Using the random-effects model, 
the pooled effect size was large and the heterogeneity was 
signifi cant (g = 0.80; Q (11) = 39.91; I2 = 72.44; p < .001).
b) Pre- to post- meta-analytic anxiety outcomes in 
adult–uncontrolled studies (Fig. 2). Of the 23 studies in-
cluded, 21 reported a signifi cant reduction in self-re-
ported anxiety (p < .02), whereas one did not (Ellard et 
Figure 2. Forest plot of the effi cacy of T-CBT on self-reported anxiety (pre-post effect sizes in adults). The fi lled squares represent the 
overall effect sizes. All RCTs used waiting list control except for Wutrich et al., (2016) that used a discussion group. The decimals are 
separated with a coma.
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al., 2010 [2]). Pooling the uncontrolled studies, the pooled 
effect size and the heterogeneity were large and signifi -
cant (g = 1.02; Q (22) = 388.01; I2 = 94.33; p < .001). 
Finally, pooling together all the studies, the effect 
size was large and the heterogeneity was signifi cant (g = 
0.91; Q (34) = 535.22; I2 = 93.65; p < .001). Moreover, 
the differences between RCTs and uncontrolled studies 
on pre- and post-anxiety measures were not signifi cant 
(Q (1) = 1.57; p = .21). 
c) Pre- to post- meta-analytic depression outcomes in 
adults–RCTs (Fig. 3). All of the 12 studies included re-
ported a signifi cant reduction in self-reported depression 
(p < 0.05). Using the random effects model and combin-
ing the RCTs, the pooled effect size was large and the 
heterogeneity was not signifi cant (g = 0.72; Q (11) = 
14.64; I2 = 24.87; p = .20). 
d) Pre- to post- meta-analytic depression outcomes in 
adults–uncontrolled studies (Fig. 3). Of the 22 studies in-
cluded, 19 reported a signifi cant reduction in self-reported 
depression (p < .05), whereas 3 did not (Bullis et al., 2015; 
Ellard et al., 2010 [1 & 2]). Combing the uncontrolled stud-
ies, the effect size was high and the heterogeneity was sig-
nifi cant (g = 1.08; Q (21) = 301.15; I2 = 93.03; p < .001). 
Pooling together all the studies, the effect size was 
large and the heterogeneity was signifi cant (g = 0.82; Q 
(33) = 441.33; I2 = 92.52; p < .001). Moreover, the dif-
ferences between the RCTs and the uncontrolled studies 
on pre- and post- depression measures were signifi cant 
(Q (1) = 7.05; p = .01). 
e) Uncontrolled pre- to follow-up meta-analytic anx-
iety outcomes in adults (Fig. 4). A total of 22 studies 
(taking into account uncontrolled studies and T-CBT vs. 
Controls studies) included follow up, 21 of which re-
ported a signifi cant reduction in self-reported anxiety 
(p <.05), whereas 1 study did not (Ellard et al., 2010 
[2]). Using the random-effects model, the pooled effect 
Figure 3. Forest plot of the effi cacy of T-CBT on self-reported depression (pre-post effect sizes in adults). The fi lled squares represent the 
overall effect sizes. All RCTs used waiting list control except for Wutrich et al., (2016), that used a discussion group. The decimals are 
separated with a coma. 
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Figure 4. Forest plot of the effi cacy of T-CBT on self-reported anxiety (uncontrolled pre-follow up effect sizes in adults). The fi lled square 
represents the overall effect size. The decimals are separated with a coma.
Figure 5. Forest plot of the effi cacy of T-CBT on self-reported depression (uncontrolled pre-follow up effect sizes in adults). The fi lled 
square represents the overall effect size. The decimals are separated with a coma.
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size was large and the heterogeneity signifi cant (g = 
1.24; Q (21) = 251.39; I2 = 91.65; p < .001). 
f) Uncontrolled pre- to follow up meta-analytic de-
pression outcomes in adults (Fig. 5). A total of 22 studies 
(taking into account uncontrolled studies and T-CBT vs 
Controls studies) included follow up, 21 of which re-
ported a signifi cant reduction in self-reported depression 
(p < .05), whereas 1 study did not (Ellard et al., 2010 
[2]). Using the random-effects model, the pooled effect 
size was in the high range and the heterogeneity was sig-
nifi cant (g = 1.19; Q (21) = 279.32; I2 = 92.48; p < .001). 
g) Pre- to post- meta-analytic anxiety outcomes of 
T-CBT vs. other therapies (Fig. 6). Of the 7 studies in-
cluded, only one (Fogliati et al., 2016) reported a signif-
icant reduction of anxiety with T-CBT in comparison 
with another treatment (in this case, disorder-specifi c 
CBT). Using the random-effects model, the pooled ef-
fect size of the studies that compared T-CBT and disor-
der-specifi c CBT was low and the heterogeneity was not 
signifi cant (g = 0.12; Q (4) = 6.52; I2 = 38.68; p = .163). 
Additionally, considering the two studies that compared 
T-CBT with TAU and relaxation training (Ejeby et al., 
2014; Norton, 2012b), the pooled effect size was low 
and the heterogeneity was not signifi cant (g = 0.24; Q (1) 
= .09; I
2
 = 0.00; p = .763).
Lastly, pooling together all the studies that compared 
T-CBT with other therapies, the effect size in anxiety 
was low and the heterogeneity was not signifi cant (g = 
0.14; Q (6) = 8.01; I2= 25.07; p = .238).
h) Pre- to post- meta-analytic depression outcomes 
in T-CBT vs. other therapies (Fig. 7). None of the 6 stud-
ies included reported a signifi cant reduction of depres-
sion with T-CBT in comparison with another treatments. 
Using the random-effects model, the pooled effect size 
of the studies that compared T-CBT and disorder-spe-
cifi c CBT was low and the heterogeneity was not signif-
icant (g = 0.05; Q (4) = 5.80; I2 < 30.97; p = .215). Addi-
tionally, only one study compared T-CBT with other 
treatment that was not disorder-specifi c CBT, specifi -
cally, with TAU (Ejeby et al., 2014): g = 0.12; p = .445. 
Lastly, pooling together all the studies that compared 
T-CBT with other therapies, the effect size in depression 
Figure 6. Forest plot of the effi cacy of T-CBT vs. DS-CBT/other therapies on self-reported anxiety (pre-post effect sizes in adults). The 
fi lled squares represent the overall effect sizes. DS-CBT = disorder specifi c cognitive-behavioral therapy; RLX = relaxation training; TAU 
= treatment as usual. The decimals are separated with a coma. 
Figure 7. Forest plot of the effi cacy of T-CBT vs. DS-CBT/other therapies on self-reported depression (pre-post effect sizes in adults). The 
fi lled squares represent the overall effect sizes. DS-CBT = disorder specifi c cognitive-behavioral therapy; RLX = relaxation training; TAU 
= treatment as usual. The decimals are separated with a coma.
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was low and the heterogeneity was not signifi cant (g = 
0.06; Q (5) = 6.08; I2= 17.75; p = .299).
i) Pre- to post- meta-analytic anxiety outcomes in 
children/adolescents (Fig. 8). Of the 5 studies included, 
2 (Bilek & Ehrenreich-May, 2012; Queen et al., 2014) 
reported a signifi cant reduction in self-reported anxiety 
(p < .05), while 3 studies did not (Chu et al., 2009; Chu 
et al., 2016; Essau et al., 2014). Using the random-ef-
fects model, the pooled effect size was moderate and the 
heterogeneity was not signifi cant (g = 0.45; Q (4) = 2.73; 
I2 < .001; p = .604]. 
j) Pre- to post- meta-analytic depression outcomes in 
children/adolescents (Fig. 9). Of the 4 studies included, 1 
(Queen et al., 2014) reported a signifi cant reduction in 
self-reported depression (p < 0.05), while 3 studies did 
not (Bilek & Ehrenreich-May, 2012; Chu et al., 2009; Chu 
et al., 2016). Using the random-effects model, the pooled 
effect size was moderate and the heterogeneity was not 
signifi cant (g = 0.50; Q (3) = 2.59; I2 < .001; p = .460). 
Risk of bias across studies
Publication bias was tested using Duval and Tweedie’s 
random effects model trim and fi ll procedure (Duval & 
Tweedie, 2000). The results are shown in Table 3. In rela-
tion to the effect sizes, the trim-and-fi ll method suggested 
that 3 out of 10 of the conducted meta-analyses studies 
should be trimmed, reducing the effect sizes in the follow-
ing meta-analysis: pre-post adult anxiety in the RCTs (from 
g = 0.80 to g = 0.62), pre-post adult depression in the RCTs 
(from g = 0.72 to g = 0.65), and pre-post adult anxiety in 
T-CBT vs. disorder-specifi c CBT (from g = 0.12 to 0.08). 
Subgroup analyses
Because we found some heterogeneity among the 
pre-post anxiety and depression outcomes in the uncon-
trolled studies and in the RCTs that compared T-CBT 
with a control group (adult population), we decided to 
conduct a series of subgroup analyses. For the categori-
cal moderator variable analyses, a random effects ANOVA 
model was used (see Table 4). We found that using a 
self-reported diagnostic measure resulted in a higher 
effect size in comparison to using a face-to-face inter-
view or a telephonic interview for both anxiety symp-
toms (Q (2) = 10.46; p = .005) and depression symptoms 
(Q (2) = 8.88; p = .012). In relation to the treatment 
components, the inclusion of problem solving strategies 
was associated with a higher effect size for depression 
(Q (1) = 4.44; p = .035). There were also signifi cant 
group differences in relation to the participants’ diagno-
sis (Q (2) = 7.13; p = .028) for depression symptoms. 
Figure 8. Forest plot of the effi cacy of T-CBT on self-reported anxiety (pre-post effect sizes in children and adolescents). The fi lled square 
represents the overall effect size. RCT = randomized controlled trial. The decimals are separated with a coma. 
Figure 9. Forest plot of the effi cacy of T-CBT on self-reported depression (pre-post effect sizes in children and adolescents). The fi lled 
square represents the overall effect size. RCT = randomized controlled trial. The decimals are separated with a coma.
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Specifi cally, those studies that did not report the partic-
ipants’ diagnosis resulted in higher effect sizes than 
those studies that only included participants with a clin-
ical diagnosis and those that also included participants 
with a subclinical diagnosis. Finally, the variable treat-
ment format (individual, group or internet) infl uenced 
outcomes for anxiety (Q (2) = 7.82; p = .020). The stud-
ies that applied an internet treatment had higher effect 
sizes than the group treatments and the individual treat-
ments. 
No indication was found that the effect sizes differed 
according to the country in which the study was con-
ducted (taking into account USA and Australia, since 
most studies were conducted in those countries), other 
treatment components apart from problem solving (be-
havioral activation, mindfulness, relaxation training and 
response prevention), the applied protocol (considering 
the most used protocols: Unifi ed Protocol, The Wellbe-
ing Program/Course, the Norton Protocol), the recruit-
ment method (community or clinical), the study design 
(RCT or uncontrolled) or the treatment target (anxiety or 
depression).
Meta-regression was used for the quantitative moder-
ator variable analysis (see Table 5), fi nding that a higher 
number of treatment sessions was associated with lower 
effect sizes in anxiety (Z = -2.21; p = .027). No indica-
tion was found that the effect sizes differed according to 
the studies’ publication date, the percentage of women in 
the sample, the percentage of participants with comorbid 
emotional disorders, the percentage of attrition, or the 
proportion of categories assessed as having a high or low 
risk of bias 7. 
In relation to the pre-test to follow-up outcomes in 
adults, no indication was found that the effect sizes dif-
fered according to the follow-up period (3 or 6 months) 
for anxiety (Q (1) = .41; p = .524) or depression (Q (1) = 
.90; p = .343).
Discussion 
Summary of evidence
This study tested the effi cacy of transdiagnostic CBT 
treatments for anxiety and depressive disorders using 48 
studies (21 RCTs and 27 uncontrolled studies) with a 
total of 6291 participants (of which 172 were children or 
adolescents). We examined the effect of transdiagnostic 
CBT protocols on outcome measures of anxiety and de-
pression. For the adult sample, the effi cacy of the proto-
cols used in RCTs was tested against a control group 
consisting of a waiting list control (WLC; 12 studies) 
and a discussion group (1 study). We also studied the 
effect of transdiagnostic CBT in the uncontrolled studies 
that reported baseline and post-treatment data (27 stud-
ies). Results for both controlled (RCTs) and uncon-
trolled trials supported the hypothesis that transdiagnos-
tic CBT is an effective treatment for reducing anxiety 
and depression in adults with principal or comorbid anx-
iety and/or depressive disorders or with subclinical lev-
els of anxiety and/or depression. We found large overall 
pre-post effect sizes for anxiety (RCTs: g = 0.80; uncon-
trolled studies: g = 1.02) and depression (RCTs: g = 
0.73; uncontrolled studies: g = 1.08). 
These results are generally consistent with the positive 
fi ndings reported in recent meta-analyses on the effects of 
transdiagnostic protocols for anxiety and depression 
(Newby et al., 2015; Norton & Philipp, 2008; Reinholt & 
Krogh, 2014). As occurred in these previous meta-analy-
ses, the present results support the hypothesis that the un-
controlled trials tend to be associated with larger effect 
sizes than the RCTs. However, based on categorical mod-
erator variable analyses on pre-post anxiety and depression 
treatment outcomes, we did not fi nd a signifi cant effect 
associated with the study design (i.e., RCT vs. uncon-
trolled trial) for anxiety or depression outcomes (p > .05). 
Our fi ndings also demonstrated that the therapeutic 
gains were maintained, or even increased, at follow-up 
(3-6 months after treatment), both for anxiety (g = 1.24) 
7 The proportion of categories assessed with a high risk of bias was 
calculated by dividing the number of categories assessed as having a risk 
of bias by 3 in the uncontrolled studies and by 6 in the RCTs (see Table 2). 









Pre-post adults AN RCTs 0.800 0.619 4
UC 1.017 1.017 0
Pre-post adults DEP RCTs 0.716 0.650 4
UC 1.077 1.077 0
Pre-follow up adults AN 1.237 1.237 0
DEP 1.191 1.191 0
Pre-post T-CBT vs 
DS-CBT
AN 0.121 0.079 1
DEP 0.045 0.045 0
Pre-post children/ 
adolescents
AN 0.454 0.454 0
DEP 0.503 0.503 0
Note. AN = anxiety; DEP = depression; DS-CBT = disorder specifi c cog-
nitive-behavioral therapy; ES = effect sizes; RCTs = randomized con-
trolled trials; T-CBT = transdiagnostic cognitive-behavioral therapy; UC = 
uncontrolled. a Using a random-effects model
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Table 4. Categorical moderator variables analyses on pre and post-anxiety and depression treatment outcomes in adults (uncontrolled 
studies and RCTs that compared T-CBT with a control group)
Subgroup analysis
Anxiety Depression
N g 95% CI p N g 95% CI p




USA 11 .82 .46/1.18 10 .80 .45/1.15
Diagnostic 
measure
Interview 18 .71 .50/.92
.005**
17 .82 .59/1.04
.012*T. interview 7 1.05 .71/1.39 7 .79 .45/1.13








No 12 .80 .46/1.15 11 .73 .40/1.06
Inclusion of 
mindfulness




No 29 1.01 .79/1.22 28 1.02 .82/1.23
Inclusion of 
problem solving




















No 24 1.01 .78/1.25 24 1.03 .82/1.25
Protocol applied a Unifi ed Protocol 6 .69 .24/1.13
.166
6 .73 .23/1.22
.437Wellbeing P/C. 8 1.18 .79/1.57 8 1.15 .74/1.56
Norton 5 .76 .31/1.20 3 .98 .28/1.67




Clinical 9 .84 .45/1.23 9 .90 .50/1.30
Participants’ 
diagnosis
Not reported 7 1.16 .80/1.52
.195
7 1.27 .94/1.60
.028*Clinical 22 .83 .60/1.05 21 .79 .58/1.00
Partly subclinical 6 1.14 .73/1.55 6 1.18 .80/1.56




RCT 12 .84 .51/1.16 12 .78 .49/1.07




ANX+DEP 27 .98 .75/1.20 27 1.03 .83/1.23
Treatment format Individual 7 .70 .33/1.07
.020*
7 .82 .42/1.22
.318Group 9 .70 .39/1.01 8 .81 .45/1.18
Internet 19 1.15 .94/1.35 19 1.09 .86/1.31
Note. N = number of studies included in the analyses; ANX = anxiety; ANX+DEP = anxiety and depression; RCT = randomized controlled trial; 
T. interview = telephonic interview; T-CBT = transdiagnostic cognitive-behavioral therapy; The Wellbeing P/C. = The Wellbeing Program or The 
Wellbeing Course. *p < 0.05 **p < 0.01 a For this variable we also included the pre-post treatment data (T-CBT group) of the following studies: Norton 
and Barrera (2012) and Norton (2012).
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and for depression (g = 1.19). This suggests that transdi-
agnostic CBT leads to large reductions of anxiety and 
depression over time in patients diagnosed with anxiety 
and/or depressive disorders. Transdiagnostic CBT also 
appears to be a powerful tool for reducing comorbid anx-
iety and depression.
An issue reported in recent published meta-analyses 
on the effi cacy of transdiagnostic protocols (Newby et 
al., 2015; Reinholt & Krogh, 2014) was the presence of 
high levels of heterogeneity. We also found signifi cant 
levels of heterogeneity for a number of outcome mea-
sures that suggests differences in the treatment effect 
sizes between the studies; such heterogeneity may contrib-
ute to uncertainty regarding the pooled estimates. Based 
on our categorical moderator variable analyses, we found 
signifi cant differences for anxiety (p < .01) and depres-
sion symptoms (p < .05) associated with the diagnostic 
measure applied (clinical interview, telephone interview, 
and self-reported). Self-reported diagnostic measures 
were used in 10 studies, all of them conducted through 
the internet (see Table 1). Specifi cally, the instruments 
used were, in most of the studies, the PHQ-9 scale to 
identify individuals with depressive disorders and the 
GAD-7 scale to identify individuals with anxiety disor-
ders. Both the PHQ-9 and the GAD-7 have good sensi-
tivity and specifi city for detecting depressive disorders 
and for detecting generalized anxiety, panic, social anx-
iety and post-traumatic stress disorder, respectively 
(Kroenke, Spitzer, Williams, & Löwe, 2010). Nonethe-
less, brief, self-administered scales should not be the 
sole means to diagnose patients, but rather used as a fi rst 
step to stratify patients into screen-negative and 
screen-positive groups, helping clinicians to interview 
only patients with high scores (Kroenke et al., 2010). 
Therefore, it is likely that some of the patients diagnosed 
using self-report measures are actually false positives 
(clinical analogs). Transdiagnostic CBT protocols are 
designed for the treatment of emotional disorders, but it 
appears that they could be particularly effective to treat 
subclinical conditions of anxiety and depression. Ac-
cordingly, studies that did not report the participants’ 
diagnoses and that included subclinical patients were as-
sociated with signifi cantly higher effect sizes for depres-
sion (p < 05). 
Transdiagnostic CBT protocols for the treatment of 
emotional disorders (anxiety and depressive disorders) 
represent a shift towards a more dimensional approach 
than disorder-specifi c CBT and contain similar basic 
core components, including psychoeducation, expo-
sure-based techniques (situational and/or interoceptive), 
and cognitive restructuring. However, some CBT trans-
diagnostic protocols also include certain additional com-
ponents, such as behavioral activation, problem solving, 
relaxation training, response prevention, and mindful-
ness meditation. While it is still unclear which supple-
mentary components lead to superior outcomes, the 
moderator variables analyses showed that studies using 
problem solving as an additional component were signif-
icantly associated with greater reductions in depression 
symptoms (p < .05). Such an association also appears to 
be present for anxiety (i.e., there was a trend that studies 
including problem solving had higher effect sizes on 
anxiety), although it was not statistically signifi cant (p = 
.09). These results are consistent with the literature (Bell 
& D’Zurilla, 2009; Hopko, Lejuez, Ruggiero, & Eifert, 
2003; Sánchez-Hernández, Méndez, & Garbe, 2014; 





95%CI Z p N Point 
estimate
95%CI Z p
Publication date 35 .05 -.02/.11 1.35 .176 34 .04 -.04/.11 1.00  .317
% of women 33 0.00 -.01/.01 .29 .768 32 0.00 -.01/.01 .25 .802
Number of sessions 33 -.04 -.08/-.01 -2.21   .027* 32 -.03 -.07/.01 -1.64 .101
% of attrition 32 .01 -.01/.02 .79 .432 32 0.00 -.01/.01 .30 .761
% of participants with 
comorbid emotional 
disorders
17 .01 0.00/.02 1.58 .114 16 0.00 -.01/.01 .46 .643
Proportion of categories 
with high bias 
assessment
35 -.97 -2.05/.10 -1.77 .076 34 -1.02 -2.11/.06 -1.85 .065
Note. N = number of studies included in the analyses. *p < 0.05 
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Vázquez et al., 2015) and should be taken into account 
when constructing new transdiagnostic protocols.
We expected that the addition of behavioral activa-
tion as a component in transdiagnostic CBT would be 
associated with larger effect sizes, especially for depres-
sion outcomes. However, we only found a statistical 
trend for depression (p = .08), suggesting that behavioral 
activation tends to favor the decrease of depressive 
symptoms. Behavioral activation is an important compo-
nent in some protocols of CBT for depression and seeks 
to emphasize the impact of behavior on mood symp-
toms. It has been shown that behavioral activation is 
equally effective as cognitive therapy or CBT for the 
treatment of depression, even for as long as 24 months 
follow-up (Mazzucchelli, Kane, & Rees, 2009). Al-
though it is not yet possible to draw fi rm conclusions, 
our results suggest the suitability of including the behav-
ioral activation component in order to maximize the effi -
cacy of the transdiagnostic CBT protocols on depressive 
symptoms. In addition, the current evidence that behav-
ioral activation could be a viable option as a low-inten-
sity guided self-help treatment for mild to moderate de-
pression (Chartier & Provencher, 2013) warrants the 
implementation of behavioral activation in internet-de-
livered transdiagnostic CBT protocols. Interestingly, the 
behavioral activation component was the most used (23 
out of the 35 studies included in the moderator analyses) 
among all additional therapeutic components.
Relaxation has a long history in clinical psychology 
as an anxiety-reduction strategy. The extant literature 
tends to suggest that relaxation has demonstrated its ef-
fi cacy, albeit without being as effi cacious as expo-
sure-based treatments for the anxiety disorders in gen-
eral and for the generalized anxiety disorder in particular, 
in terms of diagnostic severity, anxiety, worry, depres-
sion and other manifestations of psychopathology 
(Dugas et al., 2010; Norton & Price, 2007; Norton, 2012b; 
Öst & Westling, 1995). It has not surprised us that relax-
ation procedures were one of the most commonly used 
complementary core components in the transdiagnostic 
CBT protocols (22 studies). However, our results are in 
line with the data reviewed by Reinholt and Krogh 
(2014), which did not refl ect a signifi cant association be-
tween relaxation and anxiety outcomes. In fact, Reinholt 
and Krogh (2014) found that the four studies using re-
sponse prevention as a treatment component had a better 
outcome compared to the fi ve studies using relaxation 
training. In this respect, our non-signifi cant data related 
to the addition of the response prevention component 
contrasts with Reinholt and Krogh’s fi ndings.
It is interesting to note that the inclusion of an addi-
tional mindfulness/acceptance module in the transdiag-
nostic CBT protocols (6 studies) did not provide any 
additional effi cacy (i.e., increase in the effect size) in 
reducing anxiety or depression outcomes. This result is 
consistent with the evidence reported by Newby et al. 
(2015), which indicated that CBT outperformed mind-
fulness/acceptance-based treatments in reducing anxiety 
symptoms. Even though mindfulness has acquired a 
great diffusion and popularity in psychology and other 
disciplines as a powerful strategy to treat emotional and 
physical problems, its effi cacy has not yet been demon-
strated (Goyal et al., 2014; Miró et al., 2011; Öst, 2008). 
Our fi ndings also point out potential sources of hetero-
geneity related to the delivery format of the treatment. 
Curiously, in most of the transdiagnostic CBT studies in 
adults the treatment was delivered via internet. Inter-
net-delivered treatments had larger effect sizes compared 
to face-to face (individual or group treatments) for anxi-
ety. These results support the preliminary fi ndings report-
ed by Newby et al. (2015) which concluded that com-
puter/internet interventions outperformed face-to-face 
transdiagnostic treatments. Newby et al. (2015) included 
in their meta-analysis some internet transdiagnostic treat-
ments that were not transdiagnostic CBT protocols (a lot 
of them where tailored to patients’ specifi c diagnoses); 
thus, it appears that the superior effi cacy of internet-de-
livered formats is independent of the type of treatment. 
The authors suggested that the possible added benefi t of 
the internet-delivered and computerized treatments could 
be due to its highly standardized nature, which could en-
hance fi delity. In the present meta-analysis, a number of 
the internet-delivered studies were done with subclinical 
samples, so it is possible that the superiority of this treat-
ment format could be associated with the sample diagno-
sis (i.e., clinical vs. subclinical). Considering that most of 
the internet-based studies have been conducted by Titov`s 
group, we expect that other transdiagnostic internet-based 
protocols should corroborate these promising fi ndings in 
the future (González-Robles et al., 2015). 
A feature of transdiagnostic treatment is to address 
comorbidity of anxiety and depressive disorders. The 
transdiagnostic CBT protocols reviewed in the present 
meta-analysis have usually targeted either anxiety disor-
ders or both anxiety and depressive disorders. We did not 
fi nd outcome differences associated with these two types 
of treatment targets. In addition, even though there was 
some variability between studies in the percentage of co-
morbidity of emotional disorders (ranging from 52.40% 
to 100%), our quantitative moderator variable analysis 
showed no signifi cant effects due to percentage of sub-
jects with comorbid emotional disorders (anxiety disor-
ders and/or depressive disorders). This result does not 
support preliminary fi ndings reported in the Reinholt 
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and Krogh meta-analysis (2014) on the negative associ-
ation of comorbid depression with a less positive out-
come. According to the present meta-analysis, it appears 
that the degree of comorbidity does not interfere with 
the treatment outcome of transdiagnostic CBT proto-
cols. A possible explanation of this discrepancy with the 
Reinholt and Krogh results is that they included in their 
meta-analysis some studies based on not strictly transdi-
agnostic CBT protocols (only 7 out of 11 studies exam-
ined in this author’s meta-analysis were included in our 
meta-analysis). Thus, in contrast with Reinholt and Krogh, 
our fi ndings are consistent with the extent literature 
which suggests that transdiagnostic CBT can tolerate 
high levels of comorbidity (anxiety and/or depression) 
without losing effi cacy in the treatment of emotional dis-
orders (Norton et al., 2013; Paulus, Talkovsky, Hegge-
ness, & Norton, 2015). In line with the suggestions of 
Norton and Paulus (2015), we may conclude that the 
presence of a depressive disorder and/or an anxiety dis-
order has no adverse impact on treatment outcome, sup-
porting the hypothesis that patients with only an anxiety 
disorder do not differ in response to treatment from pa-
tients with anxiety and comorbid depression. 
Some authors have raised the issue that CBT for 
comorbid disorders is less effective on comorbidity 
outcomes than CBT for specifi c disorders (Craske et al., 
2007). However, more recent studies have stated that 
transdiagnostic CBT appears to be superior to disorder-
specifi c CBT in reducing comorbid anxiety symptoms 
(Norton et al., 2013). In the present meta-analysis we were 
able to examine the effect sizes of 5 studies that compared 
transdiagnostic CBT with disorder-specifi c CBT for 
comorbid anxiety and depression. Although the pooled 
effect size was not signifi cant, some studies suggested that 
transdiagnostic outperformed disorder-specifi c CBT for 
anxiety (two studies) and depression (one study) at post-
treatment. Three of the 5 studies (Dear et al., 2015; Fogliati 
et al., 2016; Titov et al., 2015b) reported outcome measures 
of anxiety and depression at long-term follow-up (i.e., 24 
months post-treatment), showing a signifi cant enduring 
enhancement of the therapeutic effects in alleviating 
anxiety and depression in the transdiagnostic CBT group 
in two of the studies (Dear et al., 2015; Fogliati et al., 
2016). Overall, these results tend to indicate that 
transdiagnostic CBT treatments somehow outperformed 
disorder-specifi c CBT on both outcome measures and also 
confi rm preliminary suggestions in the literature that 
transdiagnostic treatments may be fairly superior in 
reducing comorbid symptoms of anxiety and depression 
in comparison to disorder-specifi c CBT (Newby et al., 
2015; Norton & Paulus, 2015; Norton et al., 2013). 
Although one may conclude that a transdiagnostic CBT 
approach is more effective than a disorder-specifi c CBT 
approach for anxiety and depressive disorders when there 
are comorbid diagnoses and symptoms, it is necessary to 
conduct new analyses based on a larger number of studies 
in order to draw more defi nitive conclusions. 
While there is relatively high evidence demonstrating 
that transdiagnostic CBT is an effective treatment in ad-
dressing emotional disorders in adults, we found only 
one RCT concerning children and adolescents, four open 
trials, and a number of case studies, refl ecting just an ini-
tial development in this important area. We did not fi nd 
studies that directly compared transdiagnostic versus dis-
order-specifi c CBT with children and/or adolescents. 
The pooled effect size (g = 0.45) of the 5 studies was 
statistically signifi cant (p < .001) and suggests a medium-
sized efficacy of transdiagnostic CBT for anxiety 
disorders. In comparison to the effect size found apply-
ing other therapies for reduction of anxiety symptoms in 
children and adolescents (Reynolds, Wilson, Austin, & 
Hooper, 2012), transdiagnostic CBT is superior to non-
CBT therapies (g = 0.25), similar to generic CBT (g = 
0.53), and lower than disorder-specifi c CBT (g = 0.77). 
However, considering the preliminary nature of these re-
sults and the small number of studies, we cannot draw 
fi rm conclusions about their relative impact. Similar re-
sults were found concerning depression outcomes (over-
all g = 0.50, p < .001). This effect is similar to pooled 
effect sizes found in recent meta-analyses of disorder-
specifi c CBT for depression in children (Forti-Buratti, 
Saikia, Wilkinson, & Ramchandani, 2016), although the 
small number of studies included in the meta-analysis 
makes this result diffi cult to interpret meaningfully. Al-
though the evidence is still inconclusive, it appears that 
the effi cacy of transdiagnostic CBT protocols applied to 
children and/or adolescents is somewhat lower than the 
effi cacy of the protocols applied to adults. 
In general, the included studies showed an unclear or 
high risk of bias in most of the assessed categories with 
none of the studies having all categories rated as possess-
ing a low risk of bias (see Table 2). Therefore, a consider-
able proportion of studies were at high risk of a biased 
estimate of effect, which is consistent with previous 
meta-analysis on T-CBT (Newby et al., 2015; Reinholt & 
Krogh, 2014). In relation to the publication bias, there 
were only three meta-analyses in which studies were 
trimmed: pre- to post-anxiety outcomes on RCTs in an 
adult population, in which the treatment effect was re-
duced from a high effect size (g = 0.80) to a medium ef-
fect size (g = 0.62), pre- to post-depression outcomes on 
RCTs in an adult population, in which the treatment effect 
was reduced from a high effect size (g = 0.72) to a medium 
to high effect size (g = 0.65), and pre- to post-anxiety 
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outcomes on RCTs that compared T-CBT and disor-
der-specifi c CBT from a low effect size (g = 0.12) to a 
slightly lower effect size (g = 0.08). Therefore, most of the 
meta-analyses conducted were not at risk of having publi-
cation bias, and the three meta-analyses that were at risk 
did not have a high reduction in the effect size. 
Limitations
While these results are encouraging, some limita-
tions of this review should be taken into account. First, 
we chose to analyze anxiety and depression as generic 
outcome measures, but choosing other measures such as 
diagnosis-specifi c symptoms, transdiagnostic variables 
(e.g., negative affect), level of functioning, or client sat-
isfaction with the treatment would provide a more com-
plete understanding of the effectiveness of transdiagnos-
tic CBT. Second, both outcomes (anxiety and depression) 
were based on self-report measures and none of the stud-
ies were double-blinded, allowing the possibility of some 
contamination with self-report bias; thus, it is possible 
that a different impact of the treatment could be found 
by using clinician-rated scores of anxiety and depression 
(Pennant et al., 2015). Third, a possible shortcoming of 
the present review is that we included studies with sub-
clinical samples. Nevertheless, the utilization of psycho-
metrically defi ned subclinical, or “analogue,” samples 
has contributed substantially to our understanding of 
psychopathology and psychological treatment. It is also 
common in psychopathology to identify and clarify the 
role of clinically relevant phenomena in analogue sam-
ples before validating their importance in clinical sam-
ples (Tull, Stipelman, Salters-Pedneault, & Gratz, 2009). 
Therefore, transdiagnostic CBT being a relatively new 
kind of treatment, it is understandable that some studies 
decide to be more fl exible with the diagnosis inclusion 
criteria and not exclude subclinical participants. Fourth, 
due to the small number of studies examined, only pre-
liminary conclusions can be drawn for the effi cacy of 
transdiagnostic protocols applied to children and adoles-
cents and in comparison to the effi cacy of disorder-spe-
cifi c CBT. Lastly, the lack of consensus within the re-
search community regarding the appropriate instruments 
to measure the effectiveness of transdiagnostic CBT for 
anxiety and depressive disorders should be noted, as well 
as the way to defi ne the patients’ comorbid disorders 
(some studies reported the average number of diagnosis 
per patient, others the percentage of additional anxiety 
and/or depressive disorders, etc.). Future research on 
transdiagnostic CBT should address other important is-
sues, including the differential effi cacy of established 
protocols (both for adults and for children and adoles-
cents) and their delivery format, the therapeutic en-
hancement of additional core treatment components 
(e.g., problem solving, behavioral activation, etc.) and 
new developments (Barajas, 2015; Sánchez-Arribas, 
Chorot, Valiente, & Sandín, 2015; Sandín et al., 2016; 
Sandín, Sánchez-Arribas, Chorot, & Valiente, 2015; 
Torrents-Rodas et al., 2015), the inclusion of other trans-
diagnostic outcomes (e.g., neuroticism, positive affect, 
disorder-specifi c symptoms), and the examination of 
variables clinically relevant to the transdiagnostic CBT 
protocols, such as fi delity, feasibility, and acceptability.
Conclusions
The present meta-analysis provides evidence for the 
effi cacy of transdiagnostic CBT in reducing anxiety and 
depression in individuals with comorbid diagnoses of 
anxiety and depression. This quantitative review updates 
and extends reported evidence in recent meta-analyses 
of the effi cacy of transdiagnostic treatments for anxiety 
and depressive disorders. Overall, the RCTs showed that 
transdiagnostic CBT for anxiety and depressive disor-
ders in adults is superior to control conditions (large ef-
fect sizes), and that transdiagnostic CBT is similar (in 
the pre-post condition) or fairly superior (at follow-up) 
to disorder-specifi c CBT. Likewise, uncontrolled studies 
indicate that transdiagnostic CBT was associated with 
signifi cant reductions of anxiety and depressive symp-
toms in adults (large effect sizes) and in children/adoles-
cents (moderate effect sizes). 
As far as we know, this meta-analysis is the fi rst to 
quantitatively review the effi cacy of transdiagnostic 
CBT protocols focusing explicitly on the new transdiag-
nostic approach, excluding studies based on classical 
CBT applied to groups of several specifi c anxiety disor-
ders, hybrid protocols, tailored protocols, and non-CBT 
transdiagnostic therapies. In this respect, we only in-
cluded 7 out of 11 studies reviewed by Reinholt and Krogh 
(2014) and 15 out of 47 studies reviewed by Newby et al. 
(2015). Based on 48 selected studies (RCTs and un-
controlled trials), we reviewed the effi cacy of transdiag-
nostic CBT across (a) additional treatment core compo-
nents (behavioral activation, problem solving, relaxation 
training, response prevention, and mindfulness), (b) di-
agnostic procedures and sample diagnosis (clinical, sub-
clinical), (c) treatment delivery format (internet, face-to-
face, individual/group), (d) treatment target (anxiety 
disorders vs. anxiety and depressive disorders), and (e) 
consolidated transdiagnostic CBT protocols (UP, Well-
being P/C, T-GCBT). Overall, our fi ndings based on the 
effects of moderators suggest that the transdiagnostic 
CBT treatment effi cacy could be maximized by using an 
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internet-delivery format applied to subclinical individu-
als and by adding a complementary problem-solving 
module to the basic transdiagnostic protocol. Finally, 
our meta-analysis is the fi rst to quantitatively review the 
effi cacy of transdiagnostic CBT protocols in reducing 
anxiety and depression in children and adolescents.
The current study has several strengths, one of which 
is reviewing new recent transdiagnostic CBT studies not 
previously examined. Results reported in the present 
meta-analysis are based on 48 transdiagnostic CBT stud-
ies (6291 participants), of which 43 (21 RCTs and 22 
uncontrolled studies) were conducted with adults and 5 
(1 RCT, 4 uncontrolled) with children/adolescents. The 
most recent published transdiagnostic meta-analyses 
only included 7 transdiagnostic CBT studies conducted 
with samples of adults (3 RCTs, 4 uncontrolled; Rein-
holt & Krog, 2014) and 15 (9 RCTs, 6 uncontrolled; 
Newby et al., 2015). This study also used a more rigor-
ous criteria, both for the selection of the studies and for 
the calculation of Hedges’ g (to calculate the effect size 
of RCTs). Another strength is the comprehensive analy-
sis of potential moderator variables. This meta-analysis 
also stands out in its inclusion of studies based on child 
and adolescent samples and offers a preliminary analysis 
comparing the effi cacy of three main emerging transdi-
agnostic CBT protocols (UP, Wellbeing Program/Course, 
and T-GCBT). Finally, it sets forth a preliminary exami-
nation, based on recent RCTs, of the effi cacy of transdi-
agnostic compared with disorder-specifi c CBT.
In spite of its possible limitations, this meta-analysis 
provides positive evidence for the effi cacy of transdiag-
nostic CBT for anxiety and depressive disorders. How-
ever, the present meta-analysis also highlights the need 
for future RCTs to compare the effi cacy of transdiagnos-
tic CBT to disorder-specifi c CBT for anxiety and de-
pressive disorders. Finally, future research is particularly 
needed to determine the extent to which the effi cacy of 
transdiagnostic CBT with adults is also applicable to 
children and adolescents. In this sense, large-scale RCTs 
with good methodological quality and diagnostically 
heterogeneous samples are required to establish more re-
liable evidence on the effi cacy of transdiagnostic CBT in 
this population.
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